Antibodies For Treating Cancer

Author : Stewart Sell,Ralph Reisfeld
Publisher : Springer Science & Business Media
Page : 440 pages
File Size : 43,7 Mb
Release : 2012-12-06
Category : Medical
ISBN : 9781461251767

Get Book

Monoclonal Antibodies in Cancer by Stewart Sell,Ralph Reisfeld Pdf

This represents the third volume in a series on cancer markers pub lished by the Humana Press. The first volume, published in 1980, stressed the relationship of development and cancer as reflected in the production of markers by cancer that are also produced by normal cells during fetal development. The concept that cancer represents a problem of differentiation was introduced by Barry Pierce in describing differenti ation of teratocarcinomas. Highlighted were lymphocyte markers, alphafetoprotein, carcinoembryonic antigen, ectopic hormones, enzymes and isozymes, pregnancy proteins, and fibronectin. The second volume, published in 1982 and coedited with Britta Wahren, focused on the diagnostic use of oncological markers in human cancers, which were systematically treated on an organ by organ basis. At that time, the application of monoclonal antibodies to the identification of cancer markers was still in a very preliminary stage. A general introduc tion to monoclonal antibodies to human tumor antigens was given there by William Raschke, and other authors included coverage of those mark ers then detectable by monoclonal antibodies in their chapters.

Author : Kenneth A. Foon,Alton C. Morgan
Publisher : Springer Science & Business Media
Page : 171 pages
File Size : 43,6 Mb
Release : 2012-12-06
Category : Medical
ISBN : 9781461326274

Get Book

Monoclonal Antibody Therapy of Human Cancer by Kenneth A. Foon,Alton C. Morgan Pdf

KENNETH A. FOON and ALTON C. MORGAN, JR. Passive immunotherapy using heteroantisera for the treatment of cancer in animals and humans has been studied for over 50 years. Attempts have been made to treat animal tumors with sera from immunized syngeneic, allogeneic, or xenogeneic animals. A number of studies of passive immunotherapy using heterologous antisera in humans have also been performed. These studies have generally been attempted in patients with large tumor burdens, and as would be expected, results have been transient at best. A wide variety of solid tumors as well as leukemias and lym phomas have been treated with antisera raised in sheep, horses, rabbits, and goats. Problems such as anaphylaxis, serum sick ness, and severe cytopenias have been encountered with these antisera. There are a number of potential mechanisms by which unconju gated antibodies might be cytotoxic to tumor cells. Antibodies bound to the cell surface membrane of tumor cells may lead to cell lysis by complement-dependent or antibody-dependent cellu lar cytotoxicity. Circulating tumor cells bound by antibody may be more susceptible to phagocytosis by the reticuloendothelial system. Antibody bound to the cell surface membrane of tumor cells may enhance immunogenicity of the tumor cell leading to activation of the host's immune system.

Author : Melvyn Little
Publisher : Springer Nature
Page : 153 pages
File Size : 49,9 Mb
Release : 2021-05-10
Category : Medical
ISBN : 9783030725990

Get Book

Antibodies for Treating Cancer by Melvyn Little Pdf

This book presents a compact overview of the history, evolution and fascinating novel applications of antibodies for the treatment of cancer, leading the reader step by step to the latest advances. Interesting anecdotes, together with self-explanatory and clearly structured figures with a humorous touch, facilitate the reader’s understanding of this complex topic. Clinical cases round out the book, making it a valuable aid for professionals in their everyday practice. The growing importance of the topics covered here was highlighted by the joint award of the 2018 Nobel Prize in Chemistry to Frances H. Arnold (directed evolution of enzymes), George P. Smith (phage display of peptides) and Sir Gregory P. Winter (phage display of antibodies). Furthermore, the 2018 Nobel Prize in Physiology or Medicine was awarded to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative immune regulation. Many of the antibodies that are now being brought to market target precisely these immune checkpoint modulators. The book addresses a broad readership, ranging from professionals and experts in the field to residents and medical students.

Author : Daniel Gomez, Ana María Vázquez,Daniel F. Alonso,Amparo Macías
Publisher : Frontiers E-books
Page : 88 pages
File Size : 41,5 Mb
Release : 2024-07-01
Category : Electronic
ISBN : 9782889191185

Get Book

Anti-idiotype antibodies in cancer treatment by Daniel Gomez, Ana María Vázquez,Daniel F. Alonso,Amparo Macías Pdf

Actively induced immunotherapy is one of the most promising fields in cancer research and numerous approaches are being studied to design effective cancer vaccines. Among the treatment strategies to develop an effective immune response against tumor associated antigens is the use of anti idiotype (Ab2) mAb as antigen surrogates. Several studies in animal models have demonstrated the efficacy of these vaccines for triggering the immune system to induce specific and protective immunity against tumors of different origin. In fact, anti-idiotypic mAbs have been used successfully in cancer therapeutics to overcome the poor immunogenicity of some tumor-associated antigens, in particular those of non-protein origin. In some clinical trials, including patients with different tumors, anti-Id specific humoral and/or cellular responses following immunization were associated with improved clinical outcome. This number of Frontiers will be dedicated to anti- idiotypic antibodies and their use in cancer treatment. Different article types will be considered: original contributions, case reports, methods, hypothesis and theory, reviews, historical, etc.

Author : Robert C. Rees
Publisher : Oxford University Press, USA
Page : 469 pages
File Size : 41,9 Mb
Release : 2014
Category : Medical
ISBN : 9780199676866

Get Book

Tumor Immunology and Immunotherapy by Robert C. Rees Pdf

A comprehensive account of cancer immunity and immunotherapy, examining recent results, current areas of interest and the specific issues that are affecting the research and development of vaccines. It provides insight into how these problems may be overcome as viewed by leaders in the field.

Author : Ralph A. Reisfeld,Stewart Sell
Publisher : Unknown
Page : 636 pages
File Size : 41,8 Mb
Release : 1985
Category : Medical
ISBN : UOM:39015010648775

Get Book

Monoclonal Antibodies and Cancer Therapy by Ralph A. Reisfeld,Stewart Sell Pdf

Author : Brian A. Baldo
Publisher : Springer
Page : 610 pages
File Size : 44,9 Mb
Release : 2016-08-12
Category : Medical
ISBN : 9783319304724

Get Book

Safety of Biologics Therapy by Brian A. Baldo Pdf

This long overdue title provides a comprehensive, up-to-date, state-of-the art review of approved biologic therapies, with coverage of mechanisms of action, Indications for therapy, immunogenicity and a detailed examination of adverse effects and safety of the many and diverse therapeutic agents presented in a total of 13 chapters. It is predicted that by 2016, biologics will make up half of the world's 20 top-selling drugs and by 2018, biologic medicine sales will account for almost half of the world's 100 biggest selling drugs. Recombinant proteins dominate the growing list of the more than 200 approved biotherapeutic agents with targeted antibodies, fusion proteins and receptors; cytokines; hormones; enzymes; proteins involved in blood-clotting, homeostasis and thrombosis; vaccines; botulinum neurotoxins; and, more recently, biosimilar preparations, comprising the majority of approved biologics. Written with clinicians, other health care professionals, and researchers in mind, Safety of Biologics Therapy examines, in a single volume, the full range of issues surrounding the safety of approved biologic therapies. A good understanding of the risks and safety issues of modern biologics therapy is increasingly being demanded of all those connected with their development, handling, prescribing, administration and subsequent patient management. In addition to being of great value to clinicians in all branches of medicine, and to nurses, pharmacists and researchers, this book will prove invaluable for students taking undergraduate and graduate courses in the above disciplines and in the biomedical sciences.

Author : Veysel Kayser
Publisher : Mdpi AG
Page : 298 pages
File Size : 44,5 Mb
Release : 2022-01-25
Category : Electronic
ISBN : 3036526870

Get Book

Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers by Veysel Kayser Pdf

The book broadly deals with therapeutic monoclonal antibodies (mAbs) and various relevant topics, including different antibody formats such as Antibody-Drug Conjugates (ADC), bispecifics, nanoparticle-based mAbs and HER2+ cancers, immune checkpoint inhibitors and other closely related topics. Each paper was written by leading active research groups in their fields both from academia and industry. The book should be of interest to those scientists and researchers who develop or use biologics, biotherapeutics, biosimilars and biobetters in cancer treatment.

Author : Anonim
Publisher : Academic Press
Page : 288 pages
File Size : 53,8 Mb
Release : 2019-07-13
Category : Medical
ISBN : 9780128173176

Get Book

Drug-Induced Liver Injury by Anonim Pdf

Drug-Induced Liver Injury, Volume 85, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field. Chapters in this new release include Cell death mechanisms in DILI, Mitochondria in DILI, Primary hepatocytes and their cultures for the testing of drug-induced liver injury, MetaHeps an alternate approach to identify IDILI, Autophagy and DILI, Biomarkers and DILI, Regeneration and DILI, Drug-induced liver injury in obesity and nonalcoholic fatty liver disease, Mechanisms of Idiosyncratic Drug-Induced Liver Injury, the Evaluation and Treatment of Acetaminophen Toxicity, and much more. Includes the authority and expertise of leading contributors in pharmacology Presents the latest release in the Advances in Pharmacology series

Author : National Research Council,Institute for Laboratory Animal Research,Committee on Methods of Producing Monoclonal Antibodies
Publisher : National Academies Press
Page : 74 pages
File Size : 46,5 Mb
Release : 1999-05-06
Category : Medical
ISBN : 9780309173056

Get Book

Monoclonal Antibody Production by National Research Council,Institute for Laboratory Animal Research,Committee on Methods of Producing Monoclonal Antibodies Pdf

The American Anti-Vivisection Society (AAVS) petitioned the National Institutes of Health (NIH) on April 23, 1997, to prohibit the use of animals in the production of mAb. On September 18, 1997, NIH declined to prohibit the use of mice in mAb production, stating that "the ascites method of mAb production is scientifically appropriate for some research projects and cannot be replaced." On March 26, 1998, AAVS submitted a second petition, stating that "NIH failed to provide valid scientific reasons for not supporting a proposed ban." The office of the NIH director asked the National Research Council to conduct a study of methods of producing mAb. In response to that request, the Research Council appointed the Committee on Methods of Producing Monoclonal Antibodies, to act on behalf of the Institute for Laboratory Animal Research of the Commission on Life Sciences, to conduct the study. The 11 expert members of the committee had extensive experience in biomedical research, laboratory animal medicine, animal welfare, pain research, and patient advocacy (Appendix B). The committee was asked to determine whether there was a scientific necessity for the mouse ascites method; if so, whether the method caused pain or distress; and, if so, what could be done to minimize the pain or distress. The committee was also asked to comment on available in vitro methods; to suggest what acceptable scientific rationale, if any, there was for using the mouse ascites method; and to identify regulatory requirements for the continued use of the mouse ascites method. The committee held an open data-gathering meeting during which its members summarized data bearing on those questions. A 1-day workshop (Appendix A) was attended by 34 participants, 14 of whom made formal presentations. A second meeting was held to finalize the report. The present report was written on the basis of information in the literature and information presented at the meeting and the workshop.

Author : David M. Goldenberg
Publisher : CRC Press
Page : 336 pages
File Size : 44,6 Mb
Release : 2018-01-18
Category : Law
ISBN : 9781351078856

Get Book

Cancer Therapy with Radiolabeled Antibodies by David M. Goldenberg Pdf

Cancer Therapy with Radiolabeled Antibodies explores the most current experimental and clinical advances in the newly emerging field of cancer radioimmunotherapy (RAIT). Providing a multidisciplinary and international context, some of the world's leading experts examine the problems and prospects of RAIT from radiation, immunological, chemical, physical, physiological, and clinical perspectives with both overviews and original research. Discussions cover the up-to-date clinical results in the RAIT of ovarian, breast, colorectal, and brain cancers, as well as the current status of RAIT in the management of B cell lymphomas. Radiobiology, dosimetry, radiochemistry, targeting biology in experimental models, clinical experiences in hematopoietic and solid tumors, and new approaches to improve cancer radioimmunotherapy are also discussed. In addition, new dosimetry concepts, new labeling methods, new concepts of antibody pharmacokinetics, and new methods to enhance selective cancer radioimmunotherapy are included.

Author : Hans G. Beger,Markus Büchler,Ralph A. Reisfeld,Gregor Schulz
Publisher : Springer Science & Business Media
Page : 347 pages
File Size : 48,5 Mb
Release : 2012-12-06
Category : Medical
ISBN : 9783642737213

Get Book

Cancer Therapy by Hans G. Beger,Markus Büchler,Ralph A. Reisfeld,Gregor Schulz Pdf

A variety of new cancer therapy modalities are discussed and evaluated in this book. It aims to demonstrate that the combination of classical chemo- and radiotherapy with new approaches in the field of immunotherapy can result in an improved treatment modality. Immunotherapy in this context consists of therapy with monoclonal antibodies, hematopoietic growth factors and other lymphokines. Results of early clinical trials with IL-2, GM-CSF and monoclonal antibodies against gastrointestinal tumors and melanoma are included. The progress in regional chemotherapy strategies, for example of the liver, is shown. In addition, the development of new chemotherapeutic agents with a different mode of action as well as better tolerability is presented. The use of hormones, such as LH-RH agonists, allows hormone-dependent tumors such as prostatic and breast cancer to be treated without strong adverse reactions. These recent findings give the reader insight into exciting therapeutic directions made possible by such combined, rather than single, modalities.

Author : Anonim
Publisher : GRIN Verlag
Page : 33 pages
File Size : 55,8 Mb
Release : 2023-02-15
Category : Medical
ISBN : 9783346813305

Get Book

The role of antibodies in cancer treatment and diagnosis by Anonim Pdf

Bachelor Thesis from the year 2022 in the subject Medicine - Human Genetics, grade: 2,0, , language: English, abstract: Monoclonal antibodies in cancer therapy, future outlook, present situation. The topic is approached via a literature review article to give the reader a good overview. The report is based on online database research via PubMed, Cochrane Library, Google Scholar, and ScienceDirect. The purpose of this article is to evaluate the role of antibodies in immunology and their possibilities and limitations in cancer diagnosis and treatment. The references were chosen with regard to their relevance and actuality regarding the discussed topic. Mesh search was used, and further information regarding research tactics is provided in the methodology. In this article, we did shine a light on different aspects of monoclonal antibody usage and the general principles of this novel therapeutic approach. The general mechanism, as well as pharmaceutical preparations, are discussed. This approach lets this work present solid basics of the theoretical and practical considerations, pathways, as well as benefits and risks of monoclonal therapeutics. More research in the future could provide even more promising results and provide ways to lower mortality from cancer and, eventually, other diseases.

Author : Raymond M. Reilly
Publisher : John Wiley & Sons
Page : 849 pages
File Size : 50,9 Mb
Release : 2010-12-28
Category : Science
ISBN : 9781118035153

Get Book

Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer by Raymond M. Reilly Pdf

Oncology Book of 2011, British Medical Association's Medical Book Awards Awarded first prize in the Oncology category at the 2011 BMA Medical Book Awards, Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer helps readers understand this hot pharmaceutical field with up-to-date developments. Expert discussion covers a range of diverse topics associated with this field, including the optimization of design of biomolecules and radiochemistry, cell and animal models for preclinical evaluation, discoveries from key clinical trials, radiation biology and dosimetry, and considerations in regulatory approval. With chapters authored by internationally renowned experts, this book delivers a wealth of information to push future discovery.

Author : Benjamin Bonavida
Publisher : Springer Science & Business Media
Page : 210 pages
File Size : 54,9 Mb
Release : 2013-08-04
Category : Medical
ISBN : 9781461476542

Get Book

Resistance to Immunotherapeutic Antibodies in Cancer by Benjamin Bonavida Pdf

​​​​The traditional approaches to treat various cancers include chemotherapy, radiation and/or hormonal therapy. While these therapies continue to be effective in large part, they are not selective and highly toxic. There have been encouraging results in alternative therapeutic approach called antibody-mediated anti-cancer therapy, which is less toxic, more selective, and can also reverse drug/radiation resistance. Monoclonal antibodies or mAbs can be used to destroy malignant tumor cells and prevent tumor growth by blocking specific cell receptors. mAbs can bind only to cancer cell-specific antigens and induce an immunological response against the target cancer cell. The book covers the common and unique features of mAbs agains various cancer, gives the latest developments on the molecular, biochemical and genetic mechanisms of resistance by various mAbs, as well as discuss novel mAbs to overcome resistance.